Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 10901 - 10925 of 15183 in total
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins ... Hormones, Hormone Substitutes, and Hormone Antagonists …
Experimental
Investigational
Matched Categories: … Fluorouracil and prodrugs …
Satraplatin is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. As an investigation drug, it has not yet received U.S. Food and Drug Administration (FDA) approval and is not available in retail pharmacies.
Investigational
Matched Description: … Food and Drug Administration (FDA) approval and is not available in retail pharmacies. …
Matched Categories: … Antineoplastic and Immunomodulating Agents …
Mitoguazone has been used in trials studying the treatment of Lymphoma, HIV Infections, and Lymphoma, Non-Hodgkin.
Investigational
Matched Description: … Mitoguazone has been used in trials studying the treatment of Lymphoma, HIV Infections, and Lymphoma, …
Matched Categories: … Antineoplastic and Immunomodulating Agents …
Experimental
Matched Categories: … Antiparasitic Products, Insecticides and Repellents …
Experimental
Investigational
Withdrawn
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
ST-003 is a novel galanin receptor inhibitor being investigated for the treatment of primary sclerosing cholangitis.
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
Experimental
Matched Categories: … butizide and potassium-sparing agents ... Low-Ceiling Diuretics and Potassium-Sparing Agents …
Investigational
Matched Categories: … Enzymes and Coenzymes ... Amino Acids, Peptides, and Proteins ... Intracellular Signaling Peptides and Proteins …
EGEN-001 is a novel non-viral vector consisting of a plasmid DNA encoding the human gene for interleukin 12 (IL-12) and a biocompatible, biodegradable delivery polymer with potential antineoplastic activity.
Investigational
Matched Description: … novel non-viral vector consisting of a plasmid DNA encoding the human gene for interleukin 12 (IL-12) and
Matched Categories: … Amino Acids, Peptides, and Proteins ... Intercellular Signaling Peptides and Proteins …
Bombesin is under investigation in clinical trial NCT01205321 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers).
Investigational
Matched Description: … Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers ... NCT01205321 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and
Matched Categories: … Amino Acids, Peptides, and Proteins ... Hormones, Hormone Substitutes, and Hormone Antagonists …
Afelimomab (also known as Fab 2 or MAK 195F) is an anti-TNF-α monoclonal antibody. Administration of 195F reduces the concentration of interleukin-6 in patients with sepsis.
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins ... Antineoplastic and Immunomodulating Agents …
Experimental
Investigational
Experimental
Experimental
Experimental
Experimental
A sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and thiocholine. It is used as a reagent in the determination of butyrylcholinesterase activity. [PubChem]
Experimental
Matched Description: … sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and
Experimental
Matched Iupac: … -tetramethyl-9,27-dioxo-10,26-dioxabicyclo[23.3.1]nonacosa-1(28),5,7,13,19-pentaen-11-yl]dodecanoic acid
SQ-109 is an orally active, small molecule antibiotic for treatment of pulmonary TB. Currently in Phase I clinical trials, SQ-109 could replace one or more drugs in the current first-line TB drug regimen, simplify therapy, and shorten the TB treatment regimen.
Investigational
Matched Description: … SQ-109 could replace one or more drugs in the current first-line TB drug regimen, simplify therapy, and
Displaying drugs 10901 - 10925 of 15183 in total